Companies in the oncology sector developing innovative solutions and technologies.
Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
NeoSoma is a neuro-oncology AI platform providing AI imaging solutions for precise medical management.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
CancerNavigator offers cancer navigation and analytics, connecting patients with care experts and providing personalized support.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Atlas Oncology Partners operates a value-based oncology enablement platform supporting community oncology practices.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.
Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked